Latest Blogs

Guest Commentary
Apr 16, 2024
Surviving Hematology/Oncology Fellowship and Beyond: A Twitter Discussion With Current Fellows and Fellowship Aspirants
Following a HemOncFellows’ Network discussion on common questions aspiring and current fellows have about oncology fellowship, 10 participants, organizers, and members share practical advice that you can use in preparing for your fellowship.
Miriam Knoll, MD
Apr 09, 2024
Here’s How to Find Your Next Oncology Job: Tips for Oncologists on the Career Move
How should an oncologist investigate a career change? How does one find their second or third job out of training? Here are some strategies to consider.
Guest Commentary
Apr 04, 2024
The Best Year of Medical School: My Journey Through ASCO’s Virtual Mentorship Program
"To any medical students and residents who have a spark for oncology, I cannot recommend the VMP enough," said Zain Ahmad. "It is an experience that could change the trajectory of your career."
Guest Commentary
Mar 14, 2024
Insignificant Being and Significant Existence: A Well-Being Mindset for Oncology Professionals
When everyone is aligned with values and purpose in our societies and workplaces, we create spaces that put the well-being of all humans at the center, according to Prof. Sabe Sabesan, Anoj Sabesan, and Prof. Lynden Roberts.
Subscribe to this column

Clifford A. Hudis, MD, FASCO, FACP

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO, executive vice chair of Conquer Cancer, the ASCO Foundation, and chair of CancerLinQ. Prior to these roles, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Disclosure.

May 20, 2019
The Impact of Utilization Management on Patients and Practices: A Conversation with Dr. Jeffery Ward
Dr. Ward and I discuss the policies that public and private insurers use to control the use of anticancer drug therapies, such as prior authorization requirements, restrictive formularies, step therapy, or fail first requirements, and specialty specific tiers.
Mar 26, 2019
Exclusive Interview: NCI Director Dr. Ned Sharpless Discusses the Future of Cancer Clinical Trials
Dr. Sharpless joined me to talk about pediatric cancer research, clinical trial methodology, eligibility criteria, and more.
Mar 11, 2019
Losing a Board Member: 5 Lessons From the Life of Dr. Arti Hurria
For many of us not a day has gone by without some reminder of Arti, but last week brought it all back into sharp focus as I was asked to talk about the role we at ASCO played in her career during a symposium in her honor.
Feb 07, 2019
Exclusive Interview: FDA Commissioner Dr. Scott Gottlieb Talks Drug Pricing, Expanded Access, and Tobacco Control
Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as well as controlling the next generation of tobacco products.
Feb 01, 2019
Reflections on World Cancer Day 2019: The Challenge of “I Will”
What will each of us do, going forward, to further confront and reduce the global burden of cancer? For us at ASCO, the challenge will be answered through our mission pillars: education, research, and quality.
Jan 28, 2019
What You Need to Know About the Final 2019 Medicare Physician Fee Schedule and Quality Payment Program Rule
Editor’s note: Dr. Hudis hosts the ASCO in Action Podcast, which focuses on policy and practice issues affecting providers and patients. An excerpt of a recent episode is shared below; it has been edited for length and clarity.

Pages